Skip to content
Open access

Mismatch-Enhanced Specific PCR (MES-PCR): A Rapid and Cost-Effective Method for Screening CRISPR/Cas9-Induced Mutations

Jul 2026 · Biology · Vol 15, pp. 1089 · 0 citations · 22 references
Medicine

TL;DR

MES-PCR provides an accessible and high-throughput-compatible strategy for screening genome-edited mutants and for the preliminary evaluation of sgRNA efficiency in plant functional genomics and breeding applications.

Abstract

Simple Summary The CRISPR/Cas9 system has been widely used for genome editing, enabling the efficient generation of mutations in target genes. However, current methods for identifying these mutations, such as ACT-PCR, T7 endonuclease I (T7EI) cleavage, high-resolution melting (HRM) analysis, and high-throughput sequencing, suffer from limitations including stringent reaction conditions, high-cost reagents or instruments, operational complexity, or insufficient sensitivity for heterozygous and single-nucleotide variants. To address this, we developed a novel PCR-based method termed Mismatch-Enhanced Specific PCR (MES-PCR) for the rapid identification of CRISPR/Cas9-induced mutations. This method employs primers with artificially introduced mismatched bases, enabling high-efficiency discrimination between wild-type and mutant alleles without precise annealing temperature control. It is suitable for detecting both known and unknown mutations, including those distant from the PAM site. When coupled with quantitative PCR, the method can calculate the editing efficiency of sgRNAs and screen heterozygous mutants. We validated MES-PCR in soybean and Arabidopsis thaliana gene-edited materials, demonstrating that it has high accuracy in preliminary screening while being significantly simpler and more cost effective. Thus MES-PCR provides an accessible and high-throughput-compatible strategy for screening genome-edited mutants and for the preliminary evaluation of sgRNA efficiency in plant functional genomics and breeding applications.

Read PDF

Similar papers

Aug 2026

One-pot SP-EXPAR-integrated CRISPR/Cas14a assay for highly specific and versatile detection of ctDNA mutations in lung cancer patients.

A one-pot self-primer isothermal exponential amplification reaction (SP-EXPAR) combined with a CRISPR/Cas14a assay was developed for detecting KRAS G12C and G12D and demonstrated 100% sensitivity and 100% specificity compared with DNA sequencing.

Guozhi Yang, Ya-Qin Chen, Wenyong Zhao et al. · 0 citations
Aug 2026

Rapid PCR-based screening system for detection of type II CRISPR-Cas loci in bacterial species

This investigation aimed to device rapid and cost effective screening system for identification of new variants of Cas9 proteins in environmental bacterial species and developed and optimized a cost effective screening tool C9CSS to preliminary identify CIRISPR type-II locus in bacteria.

A. Bibi, T. Iqbal, Kainat Ilyas et al. · 0 citations
#gene editing Aug 2026

CRISPR/Cas9-Mediated Site-Directed Mutagenesis of Genes in Klebsiella pneumoniae.

This protocol minimizes off-target editing, shortens experimental timelines, reduces screening workload, and provides a reliable platform for investigating resistance mechanisms, validating candidate genes, and supporting functional genomics studies in clinically relevant bacterial pathogens.

Chun Liu, Quan Zhang, Ke Ma · 0 citations
Open access Aug 2026

Easy detection of CRISPR/Cas9-Induced Insertions, Deletions, and Substitutions in Rice Genes OsMADS26, OsRAC1 and OsNRT1.1b using SYBR Green qPCR and Robust HRM analysis in R software.

An adapted HRM workflow combining conventional SYBR Green-based qPCR chemistry with downstream computational analysis to detect CRISPR/Cas9-induced mutations at three rice loci is evaluated, supporting the potential applicability of the approach for individual sample analysis and expanded sample screening.

Bianca Cristina Carvalho Reis, Céline Georget, Anne-Cécile Meunier et al. · 0 citations
Open access Aug 2026

Integration of PNA-mediated PCR and CRISPR/Cas13a for highly sensitive detection of EGFR T790M mutation in circulating tumor DNA.

The PNA-Cas13a assay enables sensitive and specific detection of EGFR T790M mutations in ctDNA, is readily adaptable to multiple gene loci, and holds promise for clinical monitoring of tumor drug resistance.

Yang Yang, Yali Xie, Li Wang · 0 citations
Jul 2026

TOPS-CRISPR: Thermally-regulated and oligonucleotide-mediated one-pot CRISPR-Cas12a assay for ultra-sensitive and rapid on-site diagnostics.

A Thermally regulated, Oligonucleotide-mediated one-Pot System for CRISPR-Cas12a (TOPS-CRISPR), which employs a programmable inhibition strategy based on complementary RNA blockers with tunable length and binding sites, enabling efficient and reversible steric inhibition of the LbCas12a-crRNA ribonucleoprotein (RNP) co...

Shusen Ji, Bin Wang, Yi Yan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.